Lisata Therapeutics, Inc. (LSTA)

Lisata Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Selling, General & Admin	12.67	12.97	14.14	11.47	9.89	9.3
Research & Development	12.8	12.73	13.07	17.58	9.25	10.8
Operating Expenses	25.47	25.71	27.21	29.05	19.15	20.09
Operating Income	-25.47	-25.71	-27.21	-29.05	-19.15	-20.09
Interest & Investment Income	2.64	2.72	1.05	0.15	0.13	-
Other Non Operating Income (Expenses)	-0.16	-0.09	-0.06	-0.08	-	0.97
EBT Excluding Unusual Items	-22.98	-23.07	-26.21	-28.97	-19.01	-19.12
Gain (Loss) on Sale of Investments	-	-	-	-	-	-0.23
Gain (Loss) on Sale of Assets	-0.2	-0.1	-0.1	-	-	-
Pretax Income	-23.18	-23.17	-56.7	-28.97	-19.01	-19.35
Income Tax Expense	-3.13	-2.33	-2.48	-1.51	-10.87	-
Earnings From Continuing Operations	-20.05	-20.84	-54.23	-27.47	-8.14	-19.35
Net Income to Company	-20.05	-20.84	-54.23	-27.47	-8.14	-19.35
Minority Interest in Earnings	-	-	-	-	-0.01	-0.01
Net Income	-20.05	-20.84	-54.23	-27.47	-8.15	-19.36
Net Income to Common	-20.05	-20.84	-54.23	-27.47	-8.15	-19.36
Shares Outstanding (Basic)	8	8	5	4	1	1
Shares Outstanding (Diluted)	8	8	5	4	1	1
Shares Change (YoY)	32.14%	55.85%	40.46%	258.29%	49.54%	6.56%
EPS (Basic)	-2.46	-2.58	-10.47	-7.45	-7.92	-28.13
EPS (Diluted)	-2.46	-2.58	-10.47	-7.45	-7.92	-28.13
Free Cash Flow	-18.86	-20.03	-21.46	-22.31	-8.84	-18.88
Free Cash Flow Per Share	-2.31	-2.48	-4.14	-6.05	-8.59	-27.43
EBITDA	-25.28	-25.52	-27.14	-29	-19.08	-20.03
D&A For EBITDA	0.19	0.19	0.07	0.06	0.06	0.07
EBIT	-25.47	-25.71	-27.21	-29.05	-19.15	-20.09

Source: S&P Capital IQ. Standard template.